feed,title,long_url,short_url
🔐MarketWatch,Blueprint Medicines started at outperform with $80 stock price target at Oppenheimer,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=BPMC&siteid=rss,https://on.mktw.net/3KFBShN
